Valuation: UCB

Market Cap 43.13B 49.78B 40.41B 36.86B 69.29B 4,748B 70.36B 475B 186B 2,377B 187B 183B 7,927B P/E 2026 *
22.7x
P/E 2027 * 18.6x
Enterprise Value 43.34B 50.02B 40.61B 37.04B 69.63B 4,771B 70.7B 478B 187B 2,389B 188B 184B 7,966B EV / Sales 2026 *
5x
EV / Sales 2027 * 4.26x
Free-Float
61.59%
Yield 2026 *
0.64%
Yield 2027 * 0.66%
1 day-1.95%
1 week-3.23%
Current month-0.49%
1 month-5.86%
3 months-8.08%
6 months-18.96%
Current year-7.04%
1 week 219.2
Extreme 219.2
232.9
1 month 214
Extreme 214
251.5
Current year 214
Extreme 214
289.5
1 year 187.05
Extreme 187.05
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 60 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-1.95%-3.23%+18.58%+170.03% 49.77B
+0.12%+3.71%+43.22%-1.39% 79.58B
-3.73%+4.95%-2.38%+25.77% 52.73B
+0.08%+7.46%-47.52%-47.97% 46.77B
+2.44%+1.00%+61.86%-23.48% 30.13B
-0.25%+0.85%+48.04%+85.19% 24.54B
+5.12%+12.84%+147.39%-36.52% 24.18B
0.00%+10.21%+6.23%+188.24% 21.2B
+0.17%+1.83%+70.08%+164.63% 16.36B
-3.05%+18.95%-4.01%+768.95% 16.14B
Average -0.19%+4.06%+34.15%+129.34% 36.14B
Weighted average by Cap. -0.44%+3.84%+27.22%+74.89%

Financials

2026 *2027 *
Net sales 8.67B 10.01B 8.13B 7.41B 13.93B 955B 14.15B 95.57B 37.36B 478B 37.58B 36.77B 1,594B 9.68B 11.18B 9.07B 8.28B 15.56B 1,066B 15.8B 107B 41.71B 534B 41.96B 41.05B 1,780B
Net income 1.89B 2.18B 1.77B 1.61B 3.03B 208B 3.08B 20.79B 8.13B 104B 8.17B 8B 347B 2.35B 2.71B 2.2B 2B 3.77B 258B 3.83B 25.85B 10.1B 129B 10.16B 9.94B 431B
Net Debt 213M 246M 200M 182M 343M 23.5B 348M 2.35B 919M 11.77B 925M 905M 39.23B -1.9B -2.2B -1.78B -1.63B -3.06B -209B -3.1B -20.97B -8.2B -105B -8.25B -8.07B -350B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
26-08-12 221.80 -1.95% 178,654
26-08-11 €226.20 +0.49% 170,849
26-08-10 €225.10 +0.90% 195,294
26-08-07 €223.10 -0.84% 194,018
26-08-06 €225.00 -1.83% 193,762
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
226.20EUR
Average target price
286.00EUR
Spread / Average Target
+26.44%

Quarterly revenue - Rate of surprise